New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
07:55 EDTCBST, CBST, DRTX, DRTXFDA Anti-Infective Drugs Advisory Committee to hold a meeting
The Committee discusses Cubist Pharmaceuticals (CBST), (formerly Trius Therapeutics' (TSRX) new drug applications (NDAs) 205-435 and 205-436 for tedizolid phosphate tablets and tedizolid phosphate injection, respectively. Also to be discussed will be Durata Therapeutics International's (DRTX) NDA 021-883, dalbavancin hydrochloride for intravenous injection at the meeting being held at FDA Silver Spring, Maryland offices on March 31 at 8 am. []:[https://collaboration.fda.gov/aidac33114/]
News For CBST;DRTX From The Last 14 Days
Check below for free stories on CBST;DRTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
05:33 EDTCBSTCubist opens international headquarters in Zurich, will invest $400M in R&D
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use